The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

Joseph Sanchez, MD, a general surgery resident at Northwestern Medicine, Chicago, and colleagues conducted a ...

Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis.

Relesium combines the scientifically backed benefits of chicken egg powder and bovine colostrum, offering an all-natural solution for companies aiming to address digestive discomfort, such as nausea, ...

Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...

Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...

0001). Of note, hormonal therapy was associated with a lower risk for AKI (OR,.645; P < .0001). Again, GLP-1 use wasn’t significantly associated with a risk for AKI (OR, 1.138; P = .2568).

Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeek High Quality Obesity Management by ...

Morningstar brands and products Company Portfolio ...

Therefore, the researchers suggest, it might be best to follow a 24-hour clear liquid diet prior to GI endoscopy without discontinuing GLP-1 therapy. Esophagus cancer precursor being seen at ...